November 18 - 20, 2019
DoubleTree Suites by Hilton Boston - Cambridge

Agenda Day 3

8:00 am - 8:45 am 8:00 AM Registration and Coffee

8:45 am - 9:00 am Chairperson’s Opening Remarks

9:00 am - 9:40 am Overcome Manufacturing Challenges in New Biologic Modalities (Cell and Gene Therapy)

Ben Locwin, Healthcare Futurist, SVP, Quality at Lumicell

Ben Locwin

Healthcare Futurist, SVP, Quality
Lumicell

9:35 am - 10:15 am Bioprocessing Development at CuriRx

Dr. Anthony Rossomando

Head of Bioprocessing Development
CuriRX

10:20 am - 10:50 am Morning Break and Speed Networking

10:50 am - 11:30 am Ensuring Scalability with Your CMO – Dealing with a Growing Acute Issue

Ulrich Ernst, SVP Technical Operations at Iovance Biopharmaceuticals

Ulrich Ernst

SVP Technical Operations
Iovance Biopharmaceuticals

11:30 am - 12:10 pm Managing Clinical Supply and Manufacturing in a Just in Time World

Scott M. Duncan, Ph.D., Director of CMC at Centrexion Therapeutics

Scott M. Duncan, Ph.D.

Director of CMC
Centrexion Therapeutics

12:20 pm - 1:20 pm Luncheon

1:10 pm - 3:10 pm Thought Exchange Interactive Discussion Groups

3:10 pm - 3:30 pm Mid-Afternoon Break

3:30 pm - 4:10 pm Optimizing Third Party Operations in a Virtual Environment

Dr. James D. Stahl, Senior Director of Analytical Development, Contract Manufacturing Team at Promedior Inc.

Dr. James D. Stahl

Senior Director of Analytical Development, Contract Manufacturing Team
Promedior Inc.